Greenyn Biotechnology CoROCO:6846 65 OCF Margin % is 18.56% as of Dec. 2025, which is 9% below its 10-year median of 20.33. GuruFocus rates ROCO:6846 with a GF Score™ of 65/100 and a GF Value™ of NT$66.84 (Fairly Valued). The stock has 7 warning signs investors should review. Among 957 Biotechnology companies, Greenyn Biotechnology Co ranks better than 81.92% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6846 vs VRTX, REGN, ALNY: OCF Margin % Comparison
For the Biotechnology subindustry, Greenyn Biotechnology Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Greenyn Biotechnology Co OCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Greenyn Biotechnology Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Greenyn Biotechnology Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Greenyn Biotechnology Co (ROCO:6846) has a OCF Margin % of 18.56% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Greenyn Biotechnology Co and its competitors. This is near median its historical median of 20.33. Over the past decade, Greenyn Biotechnology Co's OCF Margin % has ranged from 11.79 to 38.35. According to the industry distribution chart, Greenyn Biotechnology Co ranks #173 out of 957 companies in the Biotechnology industry, placing it in the top 18.1%.
Is Greenyn Biotechnology Co's OCF Margin % too high?
Greenyn Biotechnology Co's current OCF Margin % of 18.56% is near median its 10-year median of 20.33. Over the past 10 years, this metric has ranged from a low of 11.79 to a high of 38.35. Based on the distribution chart, Greenyn Biotechnology Co ranks #173 out of 957 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Greenyn Biotechnology Co has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Greenyn Biotechnology Co's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Greenyn Biotechnology Co ranks #173 out of 957 companies for OCF Margin %. This places Greenyn Biotechnology Co in the top 18% of its industry — outperforming the majority of peers. Historically, Greenyn Biotechnology Co's own OCF Margin % has ranged from 11.79 to 38.35 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Greenyn Biotechnology Co and its competitors. Greenyn Biotechnology Co's current OCF Margin % is 18.56%, which is near median its own 10-year median of 20.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Greenyn Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Greenyn Biotechnology Co (ROCO:6846) is currently considered Fairly Valued. The stock's GF Value™ is NT$66.84, compared to a current price of NT$63.70 — trading 4.7% below its estimated fair value. The current OCF Margin % is 18.56%, which is near median its 10-year median of 20.33. Greenyn Biotechnology Co's overall GF Score™ is 65/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Greenyn Biotechnology Co (ROCO:6846), the current OCF Margin % is 18.56% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Greenyn Biotechnology Co (ROCO:6846) Overvalued in 2026?
Based on GuruFocus' analysis, Greenyn Biotechnology Co stock appears to be undervalued.
The current stock price of NT$63.70 is trading 4.7% below its estimated GF Value™ of NT$66.84.
GuruFocus considers Greenyn Biotechnology Co to be Fairly Valued.
Key valuation signals for ROCO:6846:
OCF Margin %: 18.56% (near median its 10-year median of 20.33)
GF Value™: NT$66.84 vs. price of NT$63.70 (4.7% below fair value)
No single metric tells the full story. See the ROCO:6846 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Greenyn Biotechnology Co Ltd is engaged in the business of health food raw materials production and sales of raw materials and production and sales of formula preparation.
65GF Score
Get the complete analysis for ROCO:6846
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6846 has been successfully added to your 
